| 1 |
32407876 | Cetuximab enhances oridonin-induced apoptosis through mitochondrial pathway and endoplasmic reticulum stress in laryngeal squamous cell carcinoma cells. | 2020 Sep |
1 |
| 2 |
29713280 | Oridonin Targets Multiple Drug-Resistant Tumor Cells as Determined by in Silico and in Vitro Analyses. | 2018 |
1 |
| 3 |
28411855 | Single molecule force spectroscopy for in-situ probing oridonin inhibited ROS-mediated EGF-EGFR interactions in living KYSE-150 cells. | 2017 May |
11 |
| 4 |
27667173 | Combined oridonin with cetuximab treatment shows synergistic anticancer effects on laryngeal squamous cell carcinoma: involvement of inhibition of EGFR and activation of reactive oxygen species-mediated JNK pathway. | 2016 Nov |
2 |
| 5 |
22881126 | The tyrphostin AG1478 augments oridonin-induced A431 cell apoptosis by blockage of JNK MAPK and enhancement of oxidative stress. | 2012 Nov |
6 |
| 6 |
20202741 | Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways. | 2010 Aug 28 |
3 |
| 7 |
18058384 | Oridonin induces human epidermoid carcinoma A431 cell apoptosis through tyrosine kinase and mitochondrial pathway. | 2008 Jan-Feb |
3 |
| 8 |
17251686 | Oridonin-induced A431 cell apoptosis partially through blockage of the Ras/Raf/ERK signal pathway. | 2007 Jan |
5 |
| 9 |
17268061 | Oridonin inhibited the tyrosine kinase activity and induced apoptosis in human epidermoid carcinoma A431 cells. | 2007 Feb |
10 |